FDA 483 - Texas Fertility Center - June 21, 2023

An FDA inspection of Texas Fertility Center in New Braunfels, TX, revealed a critical deficiency in their donor screening process. The facility failed to adequately screen donors for communicable disease risk factors, utilizing incomplete medical history questionnaires. This lapse could potentially compromise the safety of human cells, tissues, and cellular and tissue-based products (HCT/P).